World of DTC Marketing

JANUARY 20, 2022

We have had the best results when we use long-tail search terms like “what are the side effects of new psoriasis treatments” or “what are the symptoms of depression.” ” Who is searching for health information online?

Digital Media 232

Digital Media Media Pharma Doctors 232

European Pharmaceutical Review

DECEMBER 14, 2023

Between 1999 and 2001, it supported 17 percent of withdrawals, between 2002 and 2011, it supported 26 percent of withdrawals and by 2012 to 2016, 80 percent of withdrawals were supported by observational studies (cohort, case-control, or other epidemiologic design). Meta-analyses contributed least frequently (31.4

Safety 113

Safety Medicine Competition Networking 113

European Pharmaceutical Review

AUGUST 3, 2023

However, the EMA expressed concerns around overall efficacy and, coupled with a concern raised over possible side effects presenting as brain abnormalities suggestive of swelling or bleeding on the brain, led the EMA to the view, following a re-examination process, that it would not recommend the approval of Aduhelm. cited 2023Aug].

Food and Drug Administration 52

Food and Drug Administration Medicine FDA Marketing 52

Pharmaceutical Technology

AUGUST 17, 2022

A vaccine called Lymerix , then manufactured by SmithKline Beecham, was approved in the US in 1998 but was quickly withdrawn in 2002 due to insufficient custo mer demand. Lyme disease is also known as borreliosis, which refers to the borrelia bacteria that cause the condition. It is currently treated with antibiotics.

Side effects 119

Side effects Medicine Marketing Recruitment 119

PM360

JULY 13, 2023

Our clinical data is encouraging and supports potential registrational paths based upon its molecular design focused upon selectivity for cancer-relevant T cells and decreased side effects. What Is Your Company Currently Working On? Preliminary data are expected in 2023.

Patients 98

Patients Engineering Side effects Leads 98

European Pharmaceutical Review

SEPTEMBER 22, 2023

While new positive clinical data with anti-Abeta mAbs signal tremendous advancement and proof‑of-concept for the whole field, it is believed that the observed effects could still be improved and optimised in terms of greater clinical benefits, lower side effects and enhanced treatment convenience.

Food and Drug Administration 80

Food and Drug Administration Safety Patients Leads 80